239 related articles for article (PubMed ID: 30504228)
21. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
22. Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides.
Yamamoto K; Ishida C; Shinohara Y; Hasegawa Y; Konami Y; Osawa T; Irimura T
Biochemistry; 1994 Jul; 33(26):8159-66. PubMed ID: 7517698
[TBL] [Abstract][Full Text] [Related]
23. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
[TBL] [Abstract][Full Text] [Related]
24. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
Zaal A; Li RJE; Lübbers J; Bruijns SCM; Kalay H; van Kooyk Y; van Vliet SJ
Front Immunol; 2020; 11():305. PubMed ID: 32161592
[TBL] [Abstract][Full Text] [Related]
25. Organization of the extracellular portion of the macrophage galactose receptor: a trimeric cluster of simple binding sites for N-acetylgalactosamine.
Jégouzo SA; Quintero-Martínez A; Ouyang X; dos Santos Á; Taylor ME; Drickamer K
Glycobiology; 2013 Jul; 23(7):853-64. PubMed ID: 23507965
[TBL] [Abstract][Full Text] [Related]
26. Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth.
Lubkowski J; Durbin SV; Silva MC; Farnsworth D; Gildersleeve JC; Oliva ML; Wlodawer A
FEBS J; 2017 Feb; 284(3):429-450. PubMed ID: 27973758
[TBL] [Abstract][Full Text] [Related]
27. Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).
van Vliet SJ; Vuist IM; Lenos K; Tefsen B; Kalay H; García-Vallejo JJ; van Kooyk Y
J Biol Chem; 2013 Sep; 288(38):27519-27532. PubMed ID: 23918927
[TBL] [Abstract][Full Text] [Related]
28. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.
Napoletano C; Zizzari IG; Rughetti A; Rahimi H; Irimura T; Clausen H; Wandall HH; Belleudi F; Bellati F; Pierelli L; Frati L; Nuti M
Eur J Immunol; 2012 Apr; 42(4):936-45. PubMed ID: 22531918
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
Mazal D; Lo-Man R; Bay S; Pritsch O; Dériaud E; Ganneau C; Medeiros A; Ubillos L; Obal G; Berois N; Bollati-Fogolin M; Leclerc C; Osinaga E
Cancer Immunol Immunother; 2013 Jun; 62(6):1107-22. PubMed ID: 23604173
[TBL] [Abstract][Full Text] [Related]
30. Human Macrophage Galactose-Type Lectin (MGL) Recognizes the Outer Core of Escherichia coli Lipooligosaccharide.
Maalej M; Forgione RE; Marchetti R; Bulteau F; Thépaut M; Lanzetta R; Laguri C; Simorre JP; Fieschi F; Molinaro A; Silipo A
Chembiochem; 2019 Jul; 20(14):1778-1782. PubMed ID: 30919527
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells.
van Vliet SJ; van Liempt E; Saeland E; Aarnoudse CA; Appelmelk B; Irimura T; Geijtenbeek TB; Blixt O; Alvarez R; van Die I; van Kooyk Y
Int Immunol; 2005 May; 17(5):661-9. PubMed ID: 15802303
[TBL] [Abstract][Full Text] [Related]
32. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
33. Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea.
Wu AM
J Biomed Sci; 2005; 12(1):167-84. PubMed ID: 15864748
[TBL] [Abstract][Full Text] [Related]
34. Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
PLoS One; 2017; 12(4):e0175323. PubMed ID: 28414807
[TBL] [Abstract][Full Text] [Related]
35. The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs.
van Vliet SJ; Paessens LC; Broks-van den Berg VC; Geijtenbeek TB; van Kooyk Y
J Immunol; 2008 Sep; 181(5):3148-55. PubMed ID: 18713985
[TBL] [Abstract][Full Text] [Related]
36. MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5.
van Vliet SJ; Aarnoudse CA; Broks-van den Berg VC; Boks M; Geijtenbeek TB; van Kooyk Y
Eur J Immunol; 2007 Aug; 37(8):2075-81. PubMed ID: 17616966
[TBL] [Abstract][Full Text] [Related]
37. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
[TBL] [Abstract][Full Text] [Related]
38. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
[TBL] [Abstract][Full Text] [Related]
39. Specificity of human natural antibodies referred to as anti-Tn.
Dobrochaeva K; Khasbiullina N; Shilova N; Antipova N; Obukhova P; Ovchinnikova T; Galanina O; Blixt O; Kunz H; Filatov A; Knirel Y; LePendu J; Khaidukov S; Bovin N
Mol Immunol; 2020 Apr; 120():74-82. PubMed ID: 32087569
[TBL] [Abstract][Full Text] [Related]
40. Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
Freire T; Zhang X; Dériaud E; Ganneau C; Vichier-Guerre S; Azria E; Launay O; Lo-Man R; Bay S; Leclerc C
Blood; 2010 Nov; 116(18):3526-36. PubMed ID: 20720186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
